Helix Biopharma Corp.
HBPCF
$0.60
$0.011.70%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.89M | -7.15M | -6.85M | -6.79M | -4.55M |
| Total Depreciation and Amortization | 8.60K | 9.40K | 10.20K | 10.20K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.51M | 2.48M | 2.42M | 2.59M | 346.90K |
| Change in Net Operating Assets | 1.56M | 1.99M | 1.30M | 349.10K | -256.20K |
| Cash from Operations | -2.81M | -2.67M | -3.11M | -3.85M | -4.45M |
| Capital Expenditure | -2.90K | -2.90K | -1.50K | -10.30K | -9.60K |
| Sale of Property, Plant, and Equipment | 13.60K | 13.60K | 5.90K | -- | 3.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 10.70K | 10.70K | 4.40K | -10.30K | -5.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 406.00K |
| Issuance of Common Stock | 3.90M | 5.52M | 2.82M | 5.51M | 5.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -477.00K |
| Cash from Financing | 2.77M | 3.97M | 2.07M | 4.05M | 4.00M |
| Foreign Exchange rate Adjustments | 18.30K | 12.40K | -8.30K | -200.00 | -7.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.00K | 1.33M | -1.05M | 192.50K | -469.70K |